Perfil
Chris Beattie currently works at ViAqua Therapeutics Ltd., as Director from 2021 and AquaBounty Technologies, Inc., as Chief Scientific Officer from 2022.
Cargos activos de Chris Beattie
| Empresas | Cargo | Inicio |
|---|---|---|
| AQUABOUNTY TECHNOLOGIES, INC. | Director Técnico/Científico/I+D | 01/01/2022 |
ViAqua Therapeutics Ltd.
 ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Viaqua Therapeutics Ltd. engages in the development of drugs and therapeutics for aquaculture. Its platform for treating viral diseases in shellfish and fish utilizes a proprietary RNAi nanoparticle formulation that triggers a cell reaction to disable the viral infection. The company was founded in by Shai Einbinder and Shai Ufaz in September 2014 and is headquartered in Haifa, Israel. | Director/Miembro de la Junta | 01/11/2021 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AQUABOUNTY TECHNOLOGIES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
ViAqua Therapeutics Ltd.
ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Viaqua Therapeutics Ltd. engages in the development of drugs and therapeutics for aquaculture. Its platform for treating viral diseases in shellfish and fish utilizes a proprietary RNAi nanoparticle formulation that triggers a cell reaction to disable the viral infection. The company was founded in by Shai Einbinder and Shai Ufaz in September 2014 and is headquartered in Haifa, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Chris Beattie
